Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Pharmacology Test #4 > Respiratory Pharmacology I > Flashcards

Respiratory Pharmacology I Flashcards

1
Q

Three components influencing bronchoconsriction

A
  1. activation of mast cells
  2. local inflammation
  3. vagal stimulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is central to bronchoconstriction and airway inflammation

A

mast cell activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What do agents that increase bronchoconstriction activate?

A

7-spanning transmembrane receptors linked to internal G-proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Activation of Gq subunits results in

A

phospholipase C activation, increases in IP3, and influx of Ca2+, influx of Ca2+ results in actin-myosin coupling and smooth muscle contraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Activation of Gi subunits results in

A

decrease in adenylate cyclase activity and cAMP, incrase in PLC; resulting in bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Activation of Gs subunits results in

A

increased adenylate cyclase activity and increases in cAMP; resulting in actin-myosin dissolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What do bronchodilators do?

A

induction of smooth muscle relaxation
inhibit smooth muscle contraction
block actions of other inflammatory mediators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Agents that reduce bronchoconstriciton and increase smooth muscle relaxation share which common feature

A

increase intracellular cAMP concentrations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do sympathomimetics work

A

increase cAMP through Gs subunit of GRPRC; relax smooth muscle contraction; decrease release of mediators from mast cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sympathomimetics act through?

A

act through adenoreceptors on smooth muslce (not sympathetic innervation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name some sympathomimetics

A

epinephrine, ephedrine, isoproterenol, albuterol/salbutamol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Specificity of ephinephrine

A

both alpha and beta effects and cardiac effects preclude its use except in emergencies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Specificity of ephedrine

A

has more central effects and lower efficacy; has been replaced by selective beta-adrenergic agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Selective beta-adrenergic agents

A

albuterol, terbutaline, metaproterenol, pirbuterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How are selective beta-adrenergic agents delivered

A

delivered via airway using metered dosing devices (albuterol and terbutaline also available in oral forms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Difference between airway delivery and oral delivery of selective beta-adrenergic agents

A

little cardiac side effects with airway delivery; side effects minimal with airway delivery; oral forms associated with tremor, nervousness, and weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How may beta-adrenergic agents lead to increased perfusion-ventilation mismatch and decreased oxygenation

A

beta-adrenergic agents may act on pulmonary vascular beds resulting in vasodilation; this leads to a perfusion of poorly ventilated areas (previously vasoconstricted due to hypoxemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How can you avoid an increased perfusion-ventilation mismatch with beta-adrenergic agents

A

they’re given with oxygen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Long-acting beta-agonists

A

salmeterol and formoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How are long-acting beta-agonists used

A

used only in combination with inhaled corticosteroids for maintenance therapy; not used alone; not used for acute exacerbations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How do antimuscarinic agents work

A

reverses vagal contribution to bronchoconstriction; competitively inhibitis muscarinic receptor (block acetylcholine activation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The effectiveness of antimuscarinic agents is related to

A

muscarinic contribution to bronchospasm; limited effectiveness in allergic asthma; greater effectiveness in non-allergic conditions such as COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Antimuscarinic agents may be an alternative to

A

long-acting beta-agonists in combination with steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Atropine

A

antimuscarinic agent; effective, but has systemic side-effects even when delivered by inhalation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Ipratropium bromide
antimuscarinic agent; quaternary ammonium derivative with decreased absorption
26
Tiotropium
longer-acting selective anti-muscarinic approved for COPD
27
Methylxanthines
theophylline, caffeine, theobromine
28
Not used very commonly but remains an inexpensive alternative to other therapies
Methylxanthines
29
Mechanism of action of methylxanthines
relates to inhibition of phosphodiesterase; blocks inactivation of cAMP; results in increased intracellular levels of cAMP
30
What do methylxanthines do
cause bronchodilation and smooth muscle relaxation; also inhibits activation of inflammatory cells, including mast cells
31
What can low dose methylxanthines potentiate?
may also potentiate the action of corticosteroids in COPD
32
Systemic effects of methylxanthines mimic
mimic beta-adrenergic stimulation: cortical arousal and increased alertness, nervousness and tremor, tachycardia, increased CO, rare arrhythmias, stimulation of gastric acid and digestive enzyme secretion, increased diaphragmatic function and ventilatory effort
33
Theophylline
once commonly used as a mainline asthma drug; now used primarily in combination with steroids; less expensive than many other maintenance therapies
34
Aminophylline
theophylline-ethylenediamine complex
35
roflumilast
selective PDE4 inhibitor
36
Main issues with theophylline
wide variation in blood levels, narrow window of therapeutic range; must closely monitor blood levels to avoid toxicity
37
Side effects/toxicity symptoms with theophylline
``` tremor nervousness (therapeutic range) anorexia, nausea, vomiting, abdominal discomfort, headache anxiety (upper therapeutic range) seizures and arrhythmias (>40 mg/L) ```
38
Intracellular signaling in mast cells
increased GTP stimulates secretion | increased ATP inhibits secretion
39
Mast cell mediator blockers
``` Anti-IgE beta agonists, methylxanthines cromolyn sodium leukotriene synthesis inhibitors leukotriene receptor blockers anti-histamines ```
40
Omalizumab (Xolair)
monoclonal antibody that targets the Fc portion of IgE, preventing its attachment to the FcE receptor on mast cells and basophils
41
MOA of cromolyn sodium and nedocromil sodium
appear to inhibit mast cell degranulation by a poorly understood mechanism; also inhibits other clel types such as eosinophils
42
How is cromolyn sodium used?
Used prophylactically to inhibit asthma caused by allergen inhalation and exercise because it has no effect on bronchoconstriction; neither as potent or predictable as steroids; used as an adjunct to inhaled steroid therapies
43
How are anti-histamines used
used prophylactically, especially for allergy-induced asthma; not useful for acute exacerbations of asthma or late phase reactions
44
LTB C, D, and E act through
Cys-LT1 and Cys-LT2 (7-spanning membrane receptors with g-proteins)
45
What do leukotriene modifiers do?
cause bronchoconstriction that is slower and more persistent than histamine or cholinergic stimulation; potentiate bronchial reactivity to histamine; increase mucosal edema, hypersecretion of mucous
46
Two approaches of leukotriene modifiers
1. inhibition of 5-lipoxygenase (zileuton) | 2. LTD4 receptor antagonists (zafirlukast and montelukast)
47
Pros and cons of leukotriene modifiers
less effective against inflammation than steroids, but reduce exacerbations of bronchoconstriction; particularly effective in aspirin-induced asthma
48
What has Zileuton been associated with
liver toxicity
49
What are anti-inflammatory medications useful for
maintenance therapy of asthma not controlled by periodic use of beta-agonist inhalers
50
Mainstay of anti-inflammatory therapy
corticosteroids
51
Corticosteroids inhibit
inflammatory cell activation and cytokine production (NFk-b signaling)
52
What are steroids used
used early in an exacerbation to decrease late phase reactions
53
How are steroids best delivered
due to systemic anti-inflammatory and endocrine effects, best delivered in airway; oral and parenteral use limited to urgent cases where bronchodilators are insufficient
54
Inhaled steroids
beclomethasone, budesonide, ciclesonide, fluinisolide, fluticasone, mometasone, and triamcinolone
55
What can inhaled steroids be associated with
oropharyngeal candidiasis; may increase risk of osteoporosis and cataracts long term; may slow growth in children
56
short-acting bronchodilators
epinephrine, isoproterenol, albuterol, terbutaline, metaproterenol
57
long-acting bronchodilators
salmeterol and formoterol
58
muscarinic inhibitors
ipratropium bromide, tiotropium
59
methylxanthines
theophylline, aminophylline, dyphylline, roflumilast
60
Anti-IgE
omalizumab
61
Cromolyn
cromolyn sodium, nedocromil sodium
62
Anti-leukotrienes
zileuton, zafirlukast, montelukast
63
steroids
prednisone, beclomethasone, fluticasone, ciclesonide

Pharmacology Test #4 (9 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions